Cargando…
Effect of weight loss on cardiometabolic risk: observational analysis of two randomised controlled trials of community weight-loss programmes
BACKGROUND: Guidelines recommend that clinicians identify individuals at high cardiometabolic risk and support weight loss in those with overweight or obesity. However, we lack individual level data quantifying the benefits of weight change for individuals to guide consultations in primary care. AIM...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Royal College of General Practitioners
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7959667/ https://www.ncbi.nlm.nih.gov/pubmed/33685923 http://dx.doi.org/10.3399/bjgp20X714113 |
_version_ | 1783664998919176192 |
---|---|
author | Morris, Elizabeth Jebb, Susan A Oke, Jason Nickless, Alecia Ahern, Amy Boyland, Emma Caterson, Ian D Halford, Jason Hauner, Hans Aveyard, Paul |
author_facet | Morris, Elizabeth Jebb, Susan A Oke, Jason Nickless, Alecia Ahern, Amy Boyland, Emma Caterson, Ian D Halford, Jason Hauner, Hans Aveyard, Paul |
author_sort | Morris, Elizabeth |
collection | PubMed |
description | BACKGROUND: Guidelines recommend that clinicians identify individuals at high cardiometabolic risk and support weight loss in those with overweight or obesity. However, we lack individual level data quantifying the benefits of weight change for individuals to guide consultations in primary care. AIM: To examine how weight change affects cardiometabolic risk factors, and to facilitate shared decision making between patients and clinicians regarding weight loss. DESIGN AND SETTING: Observational analysis using data from two trials of referral of individuals with overweight or obesity in primary care to community weight-loss groups. METHOD: Linear mixed effects regression modelling examining the association between weight change and change in systolic blood pressure (SBP), diastolic blood pressure (DBP), fasting glucose, glycated haemoglobin (HbA1c), and lipid profile across multiple timepoints (baseline to 24 months). Subgroup analyses examined changes in individuals with hypertension, diabetes, and hyperlipidaemia. RESULTS: In total, 2041 participants had a mean (standard deviation) age of 50 (SD 13.5) years, mean baseline weight of 90.6 (14.8) kg and mean body mass index (BMI) of 32.7 (SD 4.1) kg/m(2). Mean (SD) weight change was −4.3 (SD 6.0) kg. All outcome measures showed statistically significant improvements. Each 1 kg weight loss was associated with 0.4 mmHg reduction in SBP and 0.3 mmHg reduction in DBP, or 0.5 mmHg and 0.4 mmHg/kg respectively in people with hypertension. Each 1 kg weight loss was associated with 0.2 mmol/mol reduction in HbA1c, or 0.6 mmol/mol in people with diabetes. Effects on plasma lipids were negligible. CONCLUSION: Weight loss achieved through referral to community weight-loss programmes, which are commonly accessible in primary care, can lead to clinically relevant reductions in BP and glucose regulation, especially in those at highest risk. |
format | Online Article Text |
id | pubmed-7959667 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Royal College of General Practitioners |
record_format | MEDLINE/PubMed |
spelling | pubmed-79596672021-03-17 Effect of weight loss on cardiometabolic risk: observational analysis of two randomised controlled trials of community weight-loss programmes Morris, Elizabeth Jebb, Susan A Oke, Jason Nickless, Alecia Ahern, Amy Boyland, Emma Caterson, Ian D Halford, Jason Hauner, Hans Aveyard, Paul Br J Gen Pract Research BACKGROUND: Guidelines recommend that clinicians identify individuals at high cardiometabolic risk and support weight loss in those with overweight or obesity. However, we lack individual level data quantifying the benefits of weight change for individuals to guide consultations in primary care. AIM: To examine how weight change affects cardiometabolic risk factors, and to facilitate shared decision making between patients and clinicians regarding weight loss. DESIGN AND SETTING: Observational analysis using data from two trials of referral of individuals with overweight or obesity in primary care to community weight-loss groups. METHOD: Linear mixed effects regression modelling examining the association between weight change and change in systolic blood pressure (SBP), diastolic blood pressure (DBP), fasting glucose, glycated haemoglobin (HbA1c), and lipid profile across multiple timepoints (baseline to 24 months). Subgroup analyses examined changes in individuals with hypertension, diabetes, and hyperlipidaemia. RESULTS: In total, 2041 participants had a mean (standard deviation) age of 50 (SD 13.5) years, mean baseline weight of 90.6 (14.8) kg and mean body mass index (BMI) of 32.7 (SD 4.1) kg/m(2). Mean (SD) weight change was −4.3 (SD 6.0) kg. All outcome measures showed statistically significant improvements. Each 1 kg weight loss was associated with 0.4 mmHg reduction in SBP and 0.3 mmHg reduction in DBP, or 0.5 mmHg and 0.4 mmHg/kg respectively in people with hypertension. Each 1 kg weight loss was associated with 0.2 mmol/mol reduction in HbA1c, or 0.6 mmol/mol in people with diabetes. Effects on plasma lipids were negligible. CONCLUSION: Weight loss achieved through referral to community weight-loss programmes, which are commonly accessible in primary care, can lead to clinically relevant reductions in BP and glucose regulation, especially in those at highest risk. Royal College of General Practitioners 2021-03-09 /pmc/articles/PMC7959667/ /pubmed/33685923 http://dx.doi.org/10.3399/bjgp20X714113 Text en © The Authors http://creativecommons.org/licenses/by/4.0/ http://creativecommons.org/licenses/by/4.0/This article is Open Access: CC BY 4.0 licence (http://creativecommons.org/licences/by/4.0/). |
spellingShingle | Research Morris, Elizabeth Jebb, Susan A Oke, Jason Nickless, Alecia Ahern, Amy Boyland, Emma Caterson, Ian D Halford, Jason Hauner, Hans Aveyard, Paul Effect of weight loss on cardiometabolic risk: observational analysis of two randomised controlled trials of community weight-loss programmes |
title | Effect of weight loss on cardiometabolic risk: observational analysis of two randomised controlled trials of community weight-loss programmes |
title_full | Effect of weight loss on cardiometabolic risk: observational analysis of two randomised controlled trials of community weight-loss programmes |
title_fullStr | Effect of weight loss on cardiometabolic risk: observational analysis of two randomised controlled trials of community weight-loss programmes |
title_full_unstemmed | Effect of weight loss on cardiometabolic risk: observational analysis of two randomised controlled trials of community weight-loss programmes |
title_short | Effect of weight loss on cardiometabolic risk: observational analysis of two randomised controlled trials of community weight-loss programmes |
title_sort | effect of weight loss on cardiometabolic risk: observational analysis of two randomised controlled trials of community weight-loss programmes |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7959667/ https://www.ncbi.nlm.nih.gov/pubmed/33685923 http://dx.doi.org/10.3399/bjgp20X714113 |
work_keys_str_mv | AT morriselizabeth effectofweightlossoncardiometabolicriskobservationalanalysisoftworandomisedcontrolledtrialsofcommunityweightlossprogrammes AT jebbsusana effectofweightlossoncardiometabolicriskobservationalanalysisoftworandomisedcontrolledtrialsofcommunityweightlossprogrammes AT okejason effectofweightlossoncardiometabolicriskobservationalanalysisoftworandomisedcontrolledtrialsofcommunityweightlossprogrammes AT nicklessalecia effectofweightlossoncardiometabolicriskobservationalanalysisoftworandomisedcontrolledtrialsofcommunityweightlossprogrammes AT ahernamy effectofweightlossoncardiometabolicriskobservationalanalysisoftworandomisedcontrolledtrialsofcommunityweightlossprogrammes AT boylandemma effectofweightlossoncardiometabolicriskobservationalanalysisoftworandomisedcontrolledtrialsofcommunityweightlossprogrammes AT catersoniand effectofweightlossoncardiometabolicriskobservationalanalysisoftworandomisedcontrolledtrialsofcommunityweightlossprogrammes AT halfordjason effectofweightlossoncardiometabolicriskobservationalanalysisoftworandomisedcontrolledtrialsofcommunityweightlossprogrammes AT haunerhans effectofweightlossoncardiometabolicriskobservationalanalysisoftworandomisedcontrolledtrialsofcommunityweightlossprogrammes AT aveyardpaul effectofweightlossoncardiometabolicriskobservationalanalysisoftworandomisedcontrolledtrialsofcommunityweightlossprogrammes |